ImmunityBio, Inc. (IBRX) Dividend History

ImmunityBio, Inc. (IBRX) is a biotechnology company focused on developing innovative immunotherapies and cancer treatments. The company specializes in next-generation immuno-oncology, aiming to enhance the body's immune response to fight cancer and infectious diseases through its proprietary platform technologies.

3530 John Hopkins Court, San Diego, CA, 92121
Phone: (844) 696-5235
Website:

Dividend History

ImmunityBio, Inc. currently does not pay dividends

Company News

  • HCW Biologics reported financial results for Q2 2024, including a net loss of $15.3 million. The company reached a settlement agreement to resolve an arbitration case, and is pursuing a financing plan including an equity offering and out-licensing of non-core assets.

    GlobeNewswire Inc.
    Featured Companies: HCWB
  • ImmunityBio (IBRX) rises 17% in the past week as it announces insurance coverage as well as the treatment of the first patients with its newly approved bladder cancer immunotherapy, Anktiva.

    Zacks Investment Research
    Featured Companies: ALXO ANVS CGEN
  • U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday. Shares of Sportradar Group AG (NASDAQ: SRAD) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter results and authorized a $200 million share repurchase program. Sportradar posted quarterly earnings of 8 cents per share, beating market estimates of 4 cents per share. The company’s quarterly sales came in at $271.88 million, beating market expectations of $271.46 million, according to data from Benzinga Pro. Sportradar Group shares jumped 10.7% to $11.17 on Wednesday. Here are some other big stocks recording gains in today’s session. Annovis Bio, Inc. (NASDAQ: ANVS) shares surged 25.6% to $11.21 after the company announced the completion of data cleaning for its Phase 2/3 study of Buntanetap in patients with mild to moderate Alzheimer's disease, with Topline efficacy data expected in April. Taysha ...

    Benzinga
  • Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results. Freshpet posted quarterly earnings of 31 cents per share, beating market estimates of 5 cents per share. The company’s quarterly sales came in at $215.42 million versus expectations of $204.36 million. Freshpet shares gained 15.5% to $106.29 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Akili, Inc. (NASDAQ: AKLI) shares jumped 126% to $0.5009 after the company reported positive results from Shionogi's Phase 3 clinical trial of localized version of Akili's EndeavorRx® for Pediatric ADHD patients in Japan. ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) climbed 126% to $1.81 after surging over 30% on Friday. MicroCloud Hologram Inc. (NASDAQ: HOLO) gained 107% to $13.71 after tumbling 40% on Friday. Neptune Wellness Solutions Inc. (NASDAQ: NEPT) rose 54.6% to $0.49. Interactive Strength Inc. (NASDAQ: TRNR) surged 32.2% to $0.8701 after the company announced it has entered into an exclusive worldwide distribution agreement with WOODWAY to sell and distribute CLMBR. Agiliti, Inc. (NASDAQ: AGTI) gained 29.4% to $9.89 after the company announced it will be taken private by THL Partners. Krystal Biotech, Inc. (NASDAQ: KRYS) surged 28.8% to $143.34 after the company reported better-than-expected financial results. R1 RCM Inc. (NYSE: RCM) surged 26.7% to $14.06 after the company received an acquisition offer for the company valued at $13.75 per share. Butterfly Network, Inc. (NASDAQ: BFLY) gained 26.3% to $1.2880. Altimmune, Inc. (NASDAQ: ALT) surged 22.1% to $11.24. Milestone Pharmaceuticals Inc. (NASDAQ: MIST) gained 21.3% to $2.10 after the company announced plans to resubmit the New Drug Application (NDA) for etripamil to the U.S. Food and Drug ...

    Benzinga
  • Shares of Intuitive Machines, Inc. (NASDAQ: LUNR) fell sharply in today’s pre-market trading. Intuitive Machines revealed Friday that its lunar lander, Odysseus, encountered a mishap during a touchdown near the moon’s south pole. Intuitive Machines shares dipped 30.1% to $6.71 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) gained 66% to $1.33 in pre-market trading after surging over 30% on Friday. Semilux International Ltd. (NASDAQ: SELX) shares rose 43.9% to $1.64 in pre-market trading after dipping 21% on Friday. Rubicon Technologies, Inc. (NYSE: RBT) shares gained 14.8% to $0.9699 in pre-market trading. NeuBase Therapeutics, Inc. (NASDAQ: NBSE) shares surged 14.5% to $0.86 in pre-market trading. Neubase Therapeutics, on Feb. 22, said board determined for company to dissolve, liquidate and distribute to stockholders its available assets. 23andMe Holding Co. (NASDAQ: ME) shares jumped 13.2% to $0.6398 in pre-market trading after ...

    Benzinga
    Featured Companies: ATCH BENF HOLO LUNR NUWE OBLG ROMA SELX SRFM ZVSA
Dividend data last updated 06/06/2025 22:47:24 UTC